2019 Q1 Form 10-Q Financial Statement

#000107997319000279 Filed on May 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1 2017
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $305.1K $960.0K $1.656M
YoY Change -68.21% 140.0% -8.84%
% of Gross Profit
Research & Development $103.5K $680.4K $426.0K
YoY Change -84.78% 693.03% 22.21%
% of Gross Profit
Depreciation & Amortization $271.00 $436.00 $1.981K
YoY Change -37.84% -13.15% -99.33%
% of Gross Profit
Operating Expenses $408.9K $1.638M $2.084M
YoY Change -75.03% 235.83% -49.71%
Operating Profit -$408.9K -$1.638M -$2.084M
YoY Change -75.03% 235.83% -49.66%
Interest Expense $100.3K $84.71K $379.2K
YoY Change 18.38% -10.49% -0.91%
% of Operating Profit
Other Income/Expense, Net -$100.3K -$92.71K -$379.2K
YoY Change 8.16% -2.04% -0.91%
Pretax Income -$509.2K -$1.730M -$2.463M
YoY Change -70.57% 198.28% -45.54%
Income Tax
% Of Pretax Income
Net Earnings -$509.2K -$1.730M -$2.463M
YoY Change -70.57% 197.17% -45.49%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$18.95K -$70.70K -$104.9K
COMMON SHARES
Basic Shares Outstanding 24.47M 23.46M
Diluted Shares Outstanding 26.84M 24.47M

Balance Sheet

Concept 2019 Q1 2018 Q1 2017
SHORT-TERM ASSETS
Cash & Short-Term Investments $149.2K $40.00K $72.93K
YoY Change 272.93% 0.0% -57.15%
Cash & Equivalents $149.2K $40.40K
Short-Term Investments
Other Short-Term Assets $5.160K $0.00 $8.410K
YoY Change -100.0% -48.21%
Inventory
Prepaid Expenses $4.164K $4.105K
Receivables
Other Receivables $1.000K $1.000K
Total Short-Term Assets $154.3K $45.51K $81.34K
YoY Change 239.13% 2.88% -58.06%
LONG-TERM ASSETS
Property, Plant & Equipment $2.964K $1.884K $3.190K
YoY Change 57.32% -31.54% -25.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.964K $1.884K $3.190K
YoY Change 57.32% -31.54% -25.12%
TOTAL ASSETS
Total Short-Term Assets $154.3K $45.51K $81.34K
Total Long-Term Assets $2.964K $1.884K $3.190K
Total Assets $157.3K $47.39K $84.53K
YoY Change 231.91% 0.87% -57.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $672.5K $950.0K $865.8K
YoY Change -29.21% 5.56% 12.7%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $20.00K $88.93K
YoY Change -100.0% -99.41%
Long-Term Debt Due $9.228M $8.970M $8.796M
YoY Change 2.88% 2.63% 2.72%
Total Short-Term Liabilities $10.78M $10.31M $11.89M
YoY Change 4.51% -31.28% 10.11%
LONG-TERM LIABILITIES
Long-Term Debt $3.619M $3.500M $3.316M
YoY Change 3.4% 1.08%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.619M $3.500M $3.316M
YoY Change 3.4% 1.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.78M $10.31M $11.89M
Total Long-Term Liabilities $3.619M $3.500M $3.316M
Total Liabilities $14.40M $13.81M $15.26M
YoY Change 4.24% -7.96% 7.96%
SHAREHOLDERS EQUITY
Retained Earnings -$123.6M -$121.4M
YoY Change 1.81% 2.77%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$14.29M -$13.82M -$15.18M
YoY Change
Total Liabilities & Shareholders Equity $157.3K $47.39K $84.53K
YoY Change 231.91% 0.87% -57.35%

Cashflow Statement

Concept 2019 Q1 2018 Q1 2017
OPERATING ACTIVITIES
Net Income -$509.2K -$1.730M -$2.463M
YoY Change -70.57% 197.17% -45.49%
Depreciation, Depletion And Amortization $271.00 $436.00 $1.981K
YoY Change -37.84% -13.15% -99.33%
Cash From Operating Activities -$197.6K -$130.0K -$516.7K
YoY Change 52.02% 30.0% -42.59%
INVESTING ACTIVITIES
Capital Expenditures -$2.480K $1.684K
YoY Change -67.48%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.480K -$1.684K
YoY Change -67.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $22.85K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 306.0K 150.0K 421.1K
YoY Change 104.0% 7.14% -42.79%
NET CHANGE
Cash From Operating Activities -197.6K -130.0K -516.7K
Cash From Investing Activities -2.480K -1.684K
Cash From Financing Activities 306.0K 150.0K 421.1K
Net Change In Cash 105.9K 20.00K -97.26K
YoY Change 429.45% -50.0% -42.48%
FREE CASH FLOW
Cash From Operating Activities -$197.6K -$130.0K -$516.7K
Capital Expenditures -$2.480K $1.684K
Free Cash Flow -$195.1K -$518.4K
YoY Change -42.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
bnet Adjustment To Additional Paid In Capital Modification Of Warrants
AdjustmentToAdditionalPaidInCapitalModificationOfWarrants
170526
bnet Adjustment To Additional Paid In Capital Modification Ofoptions
AdjustmentToAdditionalPaidInCapitalModificationOfoptions
222300
bnet Common Stock Conversions Inducements
CommonStockConversionsInducements
bnet Common Stock Conversions Inducements
CommonStockConversionsInducements
8000
CY2019Q1 bnet Common Stock Conversions Inducements
CommonStockConversionsInducements
CY2018Q1 bnet Common Stock Conversions Inducements
CommonStockConversionsInducements
8000
bnet Common Stock Voting Rights Votes Per Share
CommonStockVotingRightsVotesPerShare
1
CY2019Q1 bnet Computers And Office Equipment Gross
ComputersAndOfficeEquipmentGross
173245
bnet Conversion Of Debt And Liabilities
ConversionOfDebtAndLiabilities
100000
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018Q2 bnet Computers And Office Equipment Gross
ComputersAndOfficeEquipmentGross
171613
bnet Gain Loss On Extinguishment Of Liabilities
GainLossOnExtinguishmentOfLiabilities
718580
CY2019Q1 bnet Gain Loss On Extinguishment Of Liabilities
GainLossOnExtinguishmentOfLiabilities
CY2018Q1 bnet Gain Loss On Extinguishment Of Liabilities
GainLossOnExtinguishmentOfLiabilities
bnet Interest Expense Related To The Modification Of Warrants
InterestExpenseRelatedToTheModificationOfWarrants
7500
bnet Conversion Of Debt And Liabilities
ConversionOfDebtAndLiabilities
bnet Deferred Compensation Consecutive Trading Days
DeferredCompensationConsecutiveTradingDays
P10D
bnet Deferred Compensation Conversion Days
DeferredCompensationConversionDays
P5D
bnet Deferred Compensation Forgiven Related Parties
DeferredCompensationForgivenRelatedParties
bnet Deferred Compensation Forgiven Related Parties
DeferredCompensationForgivenRelatedParties
1685252
CY2018 bnet Deferred Compensation Liability Amount Cancelled
DeferredCompensationLiabilityAmountCancelled
2404000
CY2013Q2 bnet Extension Of Exercise Period Annual Payment Per Option Or Warrant
ExtensionOfExercisePeriodAnnualPaymentPerOptionOrWarrant
0.05
bnet Gain Loss On Extinguishment Of Liabilities
GainLossOnExtinguishmentOfLiabilities
CY2019Q1 bnet Interest Rate On Deferred Compensation
InterestRateOnDeferredCompensation
0.04
CY2019Q1 bnet Loans Payable Current Including Accrued Interest And Late Charges
LoansPayableCurrentIncludingAccruedInterestAndLateCharges
9228213
CY2018Q2 bnet Loans Payable Current Including Accrued Interest And Late Charges
LoansPayableCurrentIncludingAccruedInterestAndLateCharges
9028983
bnet Modification Of Warrants
ModificationOfWarrants
163026
bnet Proceeds From The Sale Of Units
ProceedsFromTheSaleOfUnits
792365
bnet Proceeds From The Sale Of Units
ProceedsFromTheSaleOfUnits
306997
bnet Sale Of Units Value
SaleOfUnitsValue
792365
CY2018Q4 bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
704309
CY2017Q4 bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
704309
CY2018Q2 bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
704309
CY2017Q2 bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
704309
bnet Shares Issued For Warrant Exercise Commissions
SharesIssuedForWarrantExerciseCommissions
514
bnet Shares Issued For Warrant Exercise Commissions
SharesIssuedForWarrantExerciseCommissions
bnet Stock Issued During Period Shares Commissions On Sale Of Units
StockIssuedDuringPeriodSharesCommissionsOnSaleOfUnits
1028
bnet Stock Issued During Period Value Commissions On Sale Of Units
StockIssuedDuringPeriodValueCommissionsOnSaleOfUnits
53437
bnet Warrants Issued For Unit Commissions
WarrantsIssuedForUnitCommissions
4850
bnet Warrants Issued For Unit Commissions
WarrantsIssuedForUnitCommissions
bnet Warrants Subscribed But Unissued Subscriptions Receivable
WarrantsSubscribedButUnissuedSubscriptionsReceivable
330000
bnet Warrants Subscribed But Unissued Subscriptions Receivable
WarrantsSubscribedButUnissuedSubscriptionsReceivable
134650
CY2019Q1 bnet Weighted Average Exercise Price For Outstanding Warrants
WeightedAverageExercisePriceForOutstandingWarrants
0.95
CY2019Q1 bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
425714
CY2018Q1 bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
158184
bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
1055514
CY2018Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
401470
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22013
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72932
bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
209903
CY2019Q1 bnet Weighted Average Remaining Contractual Life For Outstanding Warrants
WeightedAverageRemainingContractualLifeForOutstandingWarrants
P3Y292D
CY2019Q1 bnet Working Capital
WorkingCapital
10623000
CY2019Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
672507
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
719633
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2794421
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2794305
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
109853840
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
108117330
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
123250
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6250
CY2019Q1 us-gaap Assets
Assets
157297
CY2018Q2 us-gaap Assets
Assets
31935
CY2019Q1 us-gaap Assets Current
AssetsCurrent
154333
CY2018Q2 us-gaap Assets Current
AssetsCurrent
30487
CY2019Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
401470
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
149169
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40403
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
127156
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-32529
CY2019Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5229188
CY2019Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2018Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q1 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
504650
CY2018Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
174650
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27795695
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25939892
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27121371
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25011939
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24748213
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27091386
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25235583
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26417062
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24307630
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24043904
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Concentrations of credit risk:</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>exceed federally insured limits. The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any losses on such accounts.</div></div></div></div></div></div></div></div></div></div></div>
CY2009Q1 us-gaap Construction Loan
ConstructionLoan
7750000
CY2019Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3619099
CY2018Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3525216
CY2019Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
844122
CY2018Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
345929
CY2018Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
421641
CY2019Q1 us-gaap Depreciation
Depreciation
271
CY2018Q1 us-gaap Depreciation
Depreciation
436
us-gaap Depreciation
Depreciation
966
us-gaap Depreciation
Depreciation
1308
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
305137
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
956826
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1272626
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2077519
CY2016 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1684562
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-34189
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
80749
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
495200
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
610200
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3310
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2321
CY2019Q1 us-gaap Interest Expense
InterestExpense
100282
CY2018Q1 us-gaap Interest Expense
InterestExpense
84714
us-gaap Interest Expense
InterestExpense
290082
us-gaap Interest Expense
InterestExpense
276815
us-gaap Interest Paid Net
InterestPaidNet
us-gaap Interest Paid Net
InterestPaidNet
CY2019Q1 us-gaap Liabilities
Liabilities
14396841
CY2018Q2 us-gaap Liabilities
Liabilities
13726873
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
157297
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31935
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
10777742
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10201657
CY2019Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2222670
CY2018Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2222670
CY2019Q1 us-gaap Minority Interest
MinorityInterest
50141
CY2018Q2 us-gaap Minority Interest
MinorityInterest
54338
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
738928
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
350123
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2482
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-609290
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-382652
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-505
CY2018Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1472
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4197
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2486
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-508714
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1728940
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1946919
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2768513
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-100282
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-92714
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-290082
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
433765
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
408937
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
1637698
us-gaap Operating Expenses
OperatingExpenses
1661034
us-gaap Operating Expenses
OperatingExpenses
3204764
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-408937
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1637698
us-gaap Operating Income Loss
OperatingIncomeLoss
-1661034
us-gaap Operating Income Loss
OperatingIncomeLoss
-3204764
us-gaap Other Noncash Expense
OtherNoncashExpense
308957
us-gaap Other Noncash Expense
OtherNoncashExpense
303189
CY2019Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1000
CY2018Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
53437
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
14875
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2482
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2019Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4164
CY2018Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7474
CY2018 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
418000
CY2017 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
452000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
792000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
30500
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
40001
CY2018 us-gaap Profit Loss
ProfitLoss
-3018000
CY2017 us-gaap Profit Loss
ProfitLoss
-2463000
us-gaap Profit Loss
ProfitLoss
-1951116
us-gaap Profit Loss
ProfitLoss
-2770999
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-509219
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-1730412
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2797385
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2795753
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2964
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1448
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
12500
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
103529
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
680436
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
387442
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1125937
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-123638875
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-121691956
CY2019Q1 us-gaap Revenues
Revenues
CY2018Q1 us-gaap Revenues
Revenues
us-gaap Revenues
Revenues
us-gaap Revenues
Revenues
us-gaap Share Based Compensation
ShareBasedCompensation
2101160
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7106600
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.09
us-gaap Share Based Compensation
ShareBasedCompensation
567582
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
70625
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
350000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.35
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
57050
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6827225
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7106600
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.11
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.09
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
1.26
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.68
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
57050
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y109D
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y292D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y109D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
123250
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1376250
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
350000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.35
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
100000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
45256
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-14289685
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-13749276
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-13694938
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-14239544
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Use of estimates:</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In preparing the Company&#x2019;s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div></div></div>
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26842776
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24465814
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26291097
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24253807
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26842776
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24465814
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26291097
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24253807

Files In Submission

Name View Source Status
0001079973-19-000279-index-headers.html Edgar Link pending
0001079973-19-000279-index.html Edgar Link pending
0001079973-19-000279.txt Edgar Link pending
0001079973-19-000279-xbrl.zip Edgar Link pending
bion_10q-033119.htm Edgar Link pending
bnet-20190331.xml Edgar Link completed
bnet-20190331.xsd Edgar Link pending
bnet-20190331_cal.xml Edgar Link unprocessable
bnet-20190331_def.xml Edgar Link unprocessable
bnet-20190331_lab.xml Edgar Link unprocessable
bnet-20190331_pre.xml Edgar Link unprocessable
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32x1.htm Edgar Link pending
ex32x2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending